Genetic and environmental risk factors for sagittal craniosynostosis

Journal of Craniofacial Surgery

Volumn 13, Issue 5, 2002, Pages 602-606

  Zeiger, Joanna S ^a   Beaty, Terri H ^a   Hetmanski, Jacqueline B ^a   Wang, Hong ^d   Scott, Alan F ^b   Kasch, Laura ^b   Raymond, Gerald ^b   Jabs, Ethylin W ^b,c   VanderKolk, Craig ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Institute of Genetic Medicine   (United States)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Environmental risk factors; Gene sequencing; Sagittal craniosynostosis

Indexed keywords

ALCOHOL; CYTOSINE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GUANINE; VITAMIN; FGFR1 PROTEIN, HUMAN; FGFR2 PROTEIN, HUMAN; FGFR3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HELIX LOOP HELIX PROTEIN; NUCLEAR PROTEIN; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DISEASE ASSOCIATION; EDUCATION; ENVIRONMENTAL FACTOR; EXON; FATHER; FEMALE; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEREDITY; HUMAN; INFANT; MALE; MALFORMATION SYNDROME; NEWBORN; PEDIATRIC SURGERY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; UNITED STATES; VITAMIN INTAKE; CASE CONTROL STUDY; CONGENITAL MALFORMATION; DRINKING BEHAVIOR; EDUCATIONAL STATUS; ENVIRONMENT; GENETICS; GESTATIONAL AGE; MOTHER; MUTATION; RISK; SKULL; STATISTICAL MODEL;

ALCOHOL DRINKING; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CRANIOSYNOSTOSES; EDUCATIONAL STATUS; ENVIRONMENT; EXONS; FATHERS; FEMALE; FIBROBLAST GROWTH FACTORS; GESTATIONAL AGE; HELIX-LOOP-HELIX MOTIFS; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MOTHERS; MUTATION; NUCLEAR PROTEINS; ODDS RATIO; PARIETAL BONE; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; RISK FACTORS; SMOKING; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; VITAMINS;

EID: 0036716579     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001665-200209000-00002     Document Type: Article

References (20)

1. Wilkie AO, Wall SA. Craniosynostosis: novel insights into pathogenesis and treatment. Curr Opin in Neurol 1996;9:146-152
2. Lajeunie E, Le Merrer M, Bonaiti-Pellie C, et al. Genetic Study of Scaphocephaly. Am J Med Genet 1996;62:282-285
3. Park WJ, Bellus GA, Jabs EW. Mutations in fibroblast growth factor receptors: phenotypic consequences during eukaryotic development. Am J Hum Genet 1995;57:748-754
4. Hollway GE, Suthers GK, Haan EA, et al. Mutation detection in FGFR2 craniosynostosis syndromes. Hum Genet 1997;99: 251-255
5. Muenke M, Schell U, Hehr A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 1994;8:275-279
6. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, et al. Mutations of the TWIST gene in Saethre-Chotzen syndrome. Nature Genet 1997;15:42-46
7. Paznekas WA, Cunningham ML, Howard TD, et al. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet 1998;62:1370-1380
8. Howard TD, Paznekas WA, Green ED, et al. Mutations in TWIST, a basic heliz-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997;15:36-41
9. Alderman BW, Bradley CM, Greene C, et al. Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology 1994;50:13-18
10. Kallen K. Maternal smoking and craniosynostosis. Teratology 1999;60:146-50
11. Alderman BW, Lammer EJ, Joshua SC, et al. An epidemiologic study of craniosynostosis: risk indicators for the occurrence of craniosynostosis in Colorado. Am J Epidemiol 1988;128:431-438
12. Alderman BW, Zamudio S, Baron AE, et al. Increased risk of craniosynostosi with higher antenatal maternal altitude. Int J Epidemiol 1995;24:420-426
13. Gardner JS, Guyard-Boileau B, Alderman BW, et al. Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis. Int J Epidemiol 1998;27:64-67
14. Bradley CM, Alderman BW, Williams MA, et al. Parental occupations as risk factors for craniosynostosis in offspring. Epidemiology 1995;6:306-310
15. Meyers GA, Day D, Goldberg R, et al. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss and Pfeiffer syndromes: Evidence for missense changes, insertions, and deletion due to alternative RNA splicing. Am J Hum Genet 1998;58:491-498
16. MMWR Alcohol consumption among pregnant and childbearing-aged women in the United States, 1991 and 1995. Morbidity and Mortality Weekly Report 1997;46:346-350
17. Ebrahim SH, Luman ET, Floyd RL, et al. Alcohol consumption by pregnant women in the United States during 1988-1995. Obstet Gynecol 1998;92:187-192
18. Floyd RL, Decoufle P, Hungerford DW. Alcohol use before pregnancy recognition. Am J Prev Med 1999;17:101-107
19. Drews C, Greenland S, Flanders WD. The use of restricted controls to prevent recall bias in case-control studies of reproductive outcomes. Ann Epidemiol 1993;3:86-92
20. Khoury M, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology 1994;49:273-281